RADIATION DOSE ASSESSMENT TO FAMILY MEMBERS TAKING CARE OF NON-CANCEROUS THYROID PATIENTS TREATED WITH I-131 THERAPY IN NUCLEAR MEDICINE DEPARTMENT.

This study aimed to determine the effective doses of caregivers taking care of non-cancerous patients treated with iodine-131 (I-131). Patients (administered 185-1110 MBq of I-131) were given specific radiation safety instructions (RSI). Afterwards, caregivers were provided with thermoluminescent (TLD) dosimeter badges to be worn for 12-28 days when taking care of the patients. At the end of this period, TLD measurements were obtained. Results showed that caregivers' mean effective dose was 0.15 ± 0.15 mSv, which is far less than the international recommendations of 5 mSv. Furthermore, the effective doses had no significant correlation with administered I-131 activity to the patients, distance from the hospital, caregivers' age, educational level and mode of transport. Our study showed that radiation doses received by caregivers of non-cancerous patients are higher than that of cancerous patients, nevertheless their received doses were within the international limits, thereby indicating good compliance by the caregivers to RSI.